Carnegie Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.7M | Buy |
107,264
+953
| +0.9% | +$340K | 0.74% | 35 |
|
|
2025
Q4 | $34.8M | Sell |
106,311
-949
| -0.9% | -$301K | 0.64% | 43 |
|
|
2025
Q3 | $30.3M | Buy |
107,260
+5,334
| +5% | +$1.55M | 0.57% | 51 |
|
|
2025
Q2 | $28.5M | Buy |
101,926
+103
| +0.1% | +$29.2K | 0.57% | 50 |
|
|
2025
Q1 | $29.5M | Sell |
101,823
-2,996
| -3% | -$885K | 0.7% | 38 |
|
|
2024
Q4 | $27.3M | Buy |
104,819
+5,399
| +5% | +$1.6M | 0.78% | 29 |
|
|
2024
Q3 | $32M | Buy |
99,420
+3,660
| +4% | +$1.2M | 0.94% | 22 |
|
|
2024
Q2 | $29.9M | Buy |
95,760
+2,029
| +2% | +$596K | 0.93% | 24 |
|
|
2024
Q1 | $26.6M | Buy |
93,731
+6,678
| +8% | +$1.95M | 0.83% | 29 |
|
|
2023
Q4 | $25.1M | Buy |
87,053
+3,893
| +5% | +$1.06M | 0.86% | 28 |
|
|
2023
Q3 | $22.4M | Buy |
83,160
+3,225
| +4% | +$805K | 0.86% | 27 |
|
|
2023
Q2 | $17.7M | Buy |
79,935
+1,637
| +2% | +$380K | 0.66% | 40 |
|
|
2023
Q1 | $18.9M | Buy |
78,298
+3,273
| +4% | +$803K | 0.75% | 36 |
|
|
2022
Q4 | $19.7M | Buy |
75,025
+3,197
| +4% | +$857K | 0.85% | 29 |
|
|
2022
Q3 | $16.2M | Buy |
71,828
+3,032
| +4% | +$735K | 0.77% | 33 |
|
|
2022
Q2 | $16.7M | Sell |
68,796
-324
| -0.5% | -$79.4K | 0.76% | 35 |
|
|
2022
Q1 | $16.7M | Buy |
69,120
+1,700
| +3% | +$391K | 0.61% | 45 |
|
|
2021
Q4 | $15.2M | Sell |
67,420
-13,629
| -17% | -$2.88M | 0.5% | 65 |
|
|
2021
Q3 | $17.2M | Buy |
81,049
+1,350
| +2% | +$311K | 0.65% | 50 |
|
|
2021
Q2 | $19.4M | Buy |
79,699
+1,198
| +2% | +$295K | 0.73% | 45 |
|
|
2021
Q1 | $19.6M | Buy |
78,501
+2,949
| +4% | +$704K | 0.82% | 30 |
|
|
2020
Q4 | $17.4M | Buy |
75,552
+1,980
| +3% | +$457K | 0.78% | 38 |
|
|
2020
Q3 | $18.7M | Buy |
73,572
+2,896
| +4% | +$717K | 0.95% | 25 |
|
|
2020
Q2 | $16.6M | Sell |
70,676
-30
| -0% | -$6.84K | 0.96% | 25 |
|
|
2020
Q1 | $14.4M | Sell |
70,706
-2,750
| -4% | -$601K | 1% | 25 |
|
|
2019
Q4 | $17.7M | Buy |
73,456
+10,086
| +16% | +$2.22M | 1.02% | 22 |
|
|
2019
Q3 | $12.3M | Sell |
63,370
-5,540
| -8% | -$1.06M | 0.78% | 39 |
|
|
2019
Q2 | $12.7M | Sell |
68,910
-2,169
| -3% | -$388K | 0.83% | 34 |
|
|
2019
Q1 | $13.5M | Buy |
71,079
+18,926
| +36% | +$3.61M | 0.93% | 29 |
|
|
2018
Q4 | $10.2M | Buy |
52,153
+12,722
| +32% | +$2.48M | 0.94% | 28 |
|
|
2018
Q3 | $7.69M | Sell |
39,431
-15,463
| -28% | -$3.05M | 0.63% | 43 |
|
|
2018
Q2 | $10.6M | Buy |
54,894
+10,919
| +25% | +$1.93M | 0.81% | 35 |
|
|
2018
Q1 | $7.64M | Buy |
43,975
+13,033
| +42% | +$2.39M | 0.64% | 48 |
|
|
2017
Q4 | $5.49M | Buy |
30,942
+2,941
| +11% | +$520K | 0.49% | 64 |
|
|
2017
Q3 | $5.06M | Buy |
28,001
+3,559
| +15% | +$631K | 0.59% | 48 |
|
|
2017
Q2 | $4.26M | Buy |
24,442
+543
| +2% | +$88.3K | 0.52% | 58 |
|
|
2017
Q1 | $3.84M | Buy |
23,899
+7,308
| +44% | +$1.21M | 0.48% | 66 |
|
|
2016
Q4 | $2.54M | Buy |
16,591
+1,265
| +8% | +$190K | 0.34% | 85 |
|
|
2016
Q3 | $2.49M | Sell |
15,326
-60
| -0.4% | -$10.1K | 0.36% | 78 |
|
|
2016
Q2 | $2.63M | Buy |
15,386
+159
| +1% | +$24.7K | 0.37% | 83 |
|
|
2016
Q1 | $2.28M | Buy |
15,227
+55
| +0.4% | +$8.17K | 0.35% | 85 |
|
|
2015
Q4 | $2.31M | Sell |
15,172
-116
| -0.8% | -$18.2K | 0.4% | 72 |
|
|
2015
Q3 | $2.48M | Sell |
15,288
-3,635
| -19% | -$573K | 0.43% | 71 |
|
|
2015
Q2 | $2.9M | Buy |
18,923
+275
| +1% | +$44.1K | 0.51% | 69 |
|
|
2015
Q1 | $3.03M | Buy |
18,648
+3,900
| +26% | +$614K | 0.52% | 66 |
|
|
2014
Q4 | $2.33M | Sell |
14,748
-333
| -2% | -$51.9K | 0.44% | 78 |
|
|
2014
Q3 | $2.12M | Buy |
15,081
+1,870
| +14% | +$244K | 0.42% | 79 |
|
|
2014
Q2 | $1.56M | Buy |
+13,211
| New | +$1.53M | 0.36% | 89 |
|
Other funds holding AMGN
VCM
VPM
Carnegie Investment Counsel's AMGN Position: Q1 2026 in Review
Carnegie Investment Counsel increased its Amgen (AMGN) stake by 0.9% in Q1 2026, buying an estimated $340K and bringing the position to 107,264 shares worth $37.7M. The position accounts for 0.74% of the portfolio, ranked #35.
Carnegie Investment Counsel first reported a position in AMGN in Q2 2014 and has held it in 48 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Carnegie Investment Counsel held 107,264 shares of Amgen worth $37.7M as of Q1 2026.
- Carnegie Investment Counsel bought 953 Amgen shares in Q1 2026, an estimated $340K.
- Amgen made up 0.74% of Carnegie Investment Counsel's portfolio in Q1 2026, its #35 holding.
- Carnegie Investment Counsel first reported a position in Amgen in Q2 2014 and has held it in 48 quarters since.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Carnegie Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.